Stock-based Compensation Plans (Tables)

9 Months Ended

Jun. 30, 2024

Share-Based Payment Arrangement [Abstract]

Stock-based Compensation Expenses

Stock-based compensation expense was reported as follows in the condensed consolidated statements of operations:

	Three Months Ended June 30,				Nine Months Ended June 30,
(In thousands)	2024		2023		2024		2023
Product costs	$	70	$	63	$	212	$	202
Research and development		372		353		1,131		1,056
Selling, general and administrative		1,602		1,499		4,795		4,404
Total	$	2,044	$	1,915	$	6,138	$	5,662

Summary of Stock Option Grant Activity

Stock option grant activity was as follows:

	Nine Months Ended June 30,
	2024		2023
Stock option grant activity:
Stock options granted		283,000		305,000
Weighted average grant date fair value	$	15.69	$	15.03
Weighted average exercise price	$	33.39	$	34.79